세계의 자가 검사 시장

Global Self-Testing Market to Reach US$19.7 Billion by 2030

The global market for Self-Testing estimated at US$12.3 Billion in the year 2024, is expected to reach US$19.7 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$11.4 Billion by the end of the analysis period. Growth in the Devices segment is estimated at 9.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.2 Billion While China is Forecast to Grow at 7.9% CAGR

The Self-Testing market in the U.S. is estimated at US$3.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.

Global Self-Testing Market - Key Trends & Drivers Summarized

Why Is The Self-Testing Market Gaining Popularity?

The self-testing market is witnessing significant growth as consumers seek more convenient, private, and rapid diagnostic solutions for managing their health. The increasing awareness of preventive healthcare, along with the expansion of home-based testing kits for infectious diseases, fertility, cholesterol, and vitamin deficiencies, is driving market demand. The COVID-19 pandemic accelerated the adoption of self-testing, with at-home rapid antigen and PCR tests becoming widely available. With advancements in diagnostic technology, self-testing kits are becoming more accurate and user-friendly, enabling early detection of health conditions without the need for frequent hospital visits. Additionally, the rise of telehealth services is further integrating self-testing into digital healthcare ecosystems, allowing for remote consultation and treatment recommendations.

What Innovations Are Enhancing The Effectiveness Of Self-Testing Kits?

Recent innovations in microfluidics, biosensors, and artificial intelligence (AI)-powered diagnostics are significantly improving the accuracy and usability of self-testing devices. Lab-on-a-chip technology is enabling compact and cost-effective testing solutions, allowing for precise biochemical analysis from a small sample of blood, saliva, or urine. Smart self-testing kits equipped with Bluetooth and smartphone connectivity are allowing real-time tracking of test results, enabling users to share data with healthcare providers instantly. The integration of AI-based image recognition is further enhancing the interpretation of lateral flow tests, reducing the risk of user error. Additionally, advancements in non-invasive self-testing methods, such as breath-based glucose monitors and saliva-based genetic testing, are expanding the scope of home diagnostics.

Which Healthcare Segments Are Driving The Growth Of The Self-Testing Market?

Self-testing kits are becoming widely adopted across multiple healthcare sectors, including infectious disease screening, chronic disease management, and personalized medicine. The diabetes sector remains one of the largest consumers of self-testing devices, with continuous glucose monitoring (CGM) systems and blood sugar test strips being essential for daily disease management. The women’s health segment is also experiencing growth, with fertility and pregnancy test kits becoming more advanced and widely available. The rise of genetic self-testing, including ancestry and DNA health risk assessments, is further expanding consumer interest in at-home diagnostics. Additionally, the growing focus on preventive healthcare is increasing demand for self-testing solutions for cholesterol, cardiovascular risk assessment, and gut microbiome analysis.

What Factors Are Fueling The Growth Of The Self-Testing Market?

The growth of the self-testing market is driven by several factors, including increased health awareness, the shift toward preventive healthcare, and improvements in diagnostic technology. The expansion of e-commerce and direct-to-consumer (DTC) healthcare brands is making self-testing kits more accessible to consumers worldwide. Government approvals for at-home diagnostic devices, along with improved reimbursement policies, are further supporting market expansion. The integration of telemedicine and digital health platforms is also driving demand for self-testing kits, as they enable remote patient monitoring and reduce the burden on healthcare facilities. As self-testing technology continues to evolve, the market is expected to expand, offering more personalized and efficient healthcare solutions.

SCOPE OF STUDY:

The report analyzes the Self-Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Kits, Devices, Strips); Sample (Blood, Urine, Stool, Others); Application (Blood Pressure Test, Diabetes & Glucose Tests, Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

• 2San
• Abbott Laboratories
• Access Bio, Inc.
• ACON Laboratories, Inc.
• ARKRAY, Inc.
• Assure Tech (Hangzhou) Co., Ltd.
• Becton, Dickinson and Company (BD)
• bioLytical Laboratories Inc.
• Bionime Corporation
• BioReference Laboratories, Inc.
• Biozek Medical
• Cardinal Health
• Celltrion Inc.
• Eurofins Scientific
• Everlywell, Inc.
• F. Hoffmann-La Roche Ltd.
• Geratherm Medical AG
• Gold Standard Diagnostics
• iHealth Labs Inc.
• iuvo BioScience
• Johnson & Johnson Services, Inc.
• LetsGetChecked
• Nectar Lifesciences Ltd.
• OraSure Technologies, Inc.
• PRIMA Lab SA
• Quidel Corporation
• Selfdiagnostics
• Siemens Healthineers
• True Diagnostics, Inc.
• Wondfo

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Self-Testing - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Demand for Convenient and At-Home Health Solutions Drives Growth in Self-Testing Products
  • The Rise of Chronic Disease Management and Preventative Healthcare Expands Market Opportunity for Self-Testing Solutions
  • Surge in Consumer Awareness of Health and Wellness Drives Adoption of Self-Testing Kits for Home Use
  • Technological Advancements in Diagnostics and Testing Devices Propel Market Growth for Self-Testing Products
  • Growing Preference for Privacy and Confidentiality in Health Management Strengthens the Demand for Self-Testing Solutions
  • The Expansion of Remote Healthcare and Telemedicine Services Creates New Opportunities for Self-Testing Products
  • Increasing Regulatory Approvals and Standards for Self-Testing Devices Accelerates Consumer Confidence and Market Growth
  • The Growth of the Wellness and Fitness Sector Strengthens the Adoption of Self-Testing for Health Metrics
  • Rising Healthcare Costs Drive Demand for Affordable, At-Home Testing Solutions for Chronic Conditions
  • Increasing Investment in Digital Health and Mobile Health Apps Expands the Role of Self-Testing in Remote Monitoring
  • Consumer Demand for Real-Time, Actionable Health Data Drives the Growth of Self-Testing Kits in Multiple Market Segments
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Self-Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Self-Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World 6-Year Perspective for Self-Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 5: World 6-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 7: World 6-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World 6-Year Perspective for Strips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Cholesterol & Triglycerides Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 11: World 6-Year Perspective for Cholesterol & Triglycerides Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 12: World Recent Past, Current & Future Analysis for Pregnancy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 13: World 6-Year Perspective for Pregnancy Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for STD Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World 6-Year Perspective for STD Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Urinary Tract Infection Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 17: World 6-Year Perspective for Urinary Tract Infection Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 18: World Recent Past, Current & Future Analysis for Cancer Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 19: World 6-Year Perspective for Cancer Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Celiac disease Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World 6-Year Perspective for Celiac disease Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Thyroid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 23: World 6-Year Perspective for Thyroid Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 24: World Recent Past, Current & Future Analysis for Transaminase Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 25: World 6-Year Perspective for Transaminase Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Anemia Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World 6-Year Perspective for Anemia Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Allergy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 29: World 6-Year Perspective for Allergy Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 30: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 31: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Blood Pressure Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World 6-Year Perspective for Blood Pressure Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 34: World Recent Past, Current & Future Analysis for Diabetes & Glucose Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 35: World 6-Year Perspective for Diabetes & Glucose Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 36: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 37: World 6-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World 6-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 40: World Recent Past, Current & Future Analysis for Stool by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 41: World 6-Year Perspective for Stool by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 42: World Recent Past, Current & Future Analysis for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 43: World 6-Year Perspective for Other Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
  • TABLE 46: USA Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 47: USA 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
  • TABLE 48: USA Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 49: USA 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
  • TABLE 52: Canada Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 53: Canada 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
  • TABLE 54: Canada Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 55: Canada 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
• JAPAN
  • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
  • TABLE 58: Japan Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 59: Japan 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
  • TABLE 60: Japan Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 61: Japan 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
• CHINA
  • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
  • TABLE 64: China Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 65: China 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
  • TABLE 66: China Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 67: China 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
• EUROPE
  • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Self-Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe 6-Year Perspective for Self-Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • TABLE 70: Europe Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 71: Europe 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
  • TABLE 72: Europe Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 73: Europe 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
• FRANCE
  • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 76: France Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 77: France 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
  • TABLE 78: France Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 79: France 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
• GERMANY
  • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 82: Germany Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 83: Germany 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
  • TABLE 84: Germany Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 85: Germany 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
• ITALY
  • TABLE 88: Italy Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 89: Italy 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
  • TABLE 90: Italy Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 91: Italy 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
• UNITED KINGDOM
  • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 94: UK Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 95: UK 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
  • TABLE 96: UK Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 97: UK 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
  • TABLE 98: UK Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: UK 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
• REST OF EUROPE
  • TABLE 100: Rest of Europe Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 101: Rest of Europe 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
  • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 103: Rest of Europe 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
  • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Rest of Europe 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
• ASIA-PACIFIC
  • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 106: Asia-Pacific Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 107: Asia-Pacific 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
  • TABLE 108: Asia-Pacific Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 109: Asia-Pacific 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
  • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Asia-Pacific 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
• REST OF WORLD
  • TABLE 112: Rest of World Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 113: Rest of World 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
  • TABLE 114: Rest of World Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 115: Rest of World 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
  • TABLE 116: Rest of World Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Rest of World 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030

IV. COMPETITION